Arcutis Biotherapeutics (ARQT) SEC Filings: History & Chart

Arcutis Biotherapeutics, Inc.(ARQT)

Biotechnology · Westlake Village, CA

$25.15-0.01 (-0.04%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.

Westlake Village, CA

354 employees

www.arcutis.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Todd Franklin Watanabe

View full financials

Form	Filing Date	Accepted	Document
SC 13G/A	Oct 5, 2026	Oct 5, 2026	View filing
4	Sep 18, 2026	Sep 18, 2026	View filing
4	Sep 17, 2026	Sep 17, 2026	View filing
4	Sep 10, 2026	Sep 10, 2026	View filing
4	Aug 28, 2026	Aug 28, 2026	View filing
4	Aug 24, 2026	Aug 24, 2026	View filing
4	Aug 21, 2026	Aug 21, 2026	View filing
4	Aug 19, 2026	Aug 19, 2026	View filing
SC 13G	Aug 14, 2026	Aug 14, 2026	View filing
4	Aug 13, 2026	Aug 13, 2026	View filing
SC 13G	Aug 7, 2026	Aug 7, 2026	View filing
4	Aug 5, 2026	Aug 5, 2026	View filing
4	Aug 5, 2026	Aug 5, 2026	View filing
4	Aug 5, 2026	Aug 5, 2026	View filing
10-Q	Aug 5, 2026	Aug 5, 2026	View filing
8-K	Aug 5, 2026	Aug 5, 2026	View filing
4	Jul 17, 2026	Jul 17, 2026	View filing
3	Jul 17, 2026	Jul 17, 2026	View filing
4	Jul 17, 2026	Jul 17, 2026	View filing
8-K	Jul 16, 2026	Jul 16, 2026	View filing
4	Jun 17, 2026	Jun 17, 2026	View filing
4	Jun 17, 2026	Jun 17, 2026	View filing
4/A	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 9, 2026	Jun 9, 2026	View filing
4	Jun 9, 2026	Jun 9, 2026	View filing
4	Jun 9, 2026	Jun 9, 2026	View filing
4	Jun 9, 2026	Jun 9, 2026	View filing
4	Jun 9, 2026	Jun 9, 2026	View filing
4	Jun 9, 2026	Jun 9, 2026	View filing
4	Jun 9, 2026	Jun 9, 2026	View filing

SEC Filings

Recent Filings